1. Home
  2. AMPH vs EFC Comparison

AMPH vs EFC Comparison

Compare AMPH & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EFC
  • Stock Information
  • Founded
  • AMPH 1996
  • EFC 2007
  • Country
  • AMPH United States
  • EFC United States
  • Employees
  • AMPH N/A
  • EFC N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EFC Real Estate
  • Sector
  • AMPH Health Care
  • EFC Finance
  • Exchange
  • AMPH Nasdaq
  • EFC Nasdaq
  • Market Cap
  • AMPH 1.1B
  • EFC 1.2B
  • IPO Year
  • AMPH 2014
  • EFC 2010
  • Fundamental
  • Price
  • AMPH $21.67
  • EFC $13.17
  • Analyst Decision
  • AMPH Hold
  • EFC Buy
  • Analyst Count
  • AMPH 5
  • EFC 5
  • Target Price
  • AMPH $38.00
  • EFC $14.30
  • AVG Volume (30 Days)
  • AMPH 462.5K
  • EFC 900.6K
  • Earning Date
  • AMPH 08-07-2025
  • EFC 08-07-2025
  • Dividend Yield
  • AMPH N/A
  • EFC 11.85%
  • EPS Growth
  • AMPH N/A
  • EFC 105.71
  • EPS
  • AMPH 2.77
  • EFC 1.38
  • Revenue
  • AMPH $730,659,000.00
  • EFC $308,374,000.00
  • Revenue This Year
  • AMPH $0.92
  • EFC N/A
  • Revenue Next Year
  • AMPH $5.55
  • EFC $12.52
  • P/E Ratio
  • AMPH $7.84
  • EFC $9.52
  • Revenue Growth
  • AMPH 8.05
  • EFC 26.77
  • 52 Week Low
  • AMPH $20.43
  • EFC $11.12
  • 52 Week High
  • AMPH $53.96
  • EFC $14.40
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 41.15
  • EFC 51.73
  • Support Level
  • AMPH $20.43
  • EFC $13.04
  • Resistance Level
  • AMPH $22.90
  • EFC $13.43
  • Average True Range (ATR)
  • AMPH 0.73
  • EFC 0.17
  • MACD
  • AMPH 0.15
  • EFC -0.02
  • Stochastic Oscillator
  • AMPH 50.20
  • EFC 32.05

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: